NCT01731093View on ClinicalTrials.gov

Safety and Tolerability of Antioxidant (AT-001)for Reducing Brain Oxidative Stress

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

December 31, 2013

Conditions
Oxidative Stress
Interventions
DRUG

AT-001

DRUG

Placebo

Trial Locations (1)

40536

University of Kentucky Alzheimer's Disease Research Center, Lexington

Sponsors
All Listed Sponsors
lead

Alltech Life Sciences Inc.

INDUSTRY